1 / 27

Process Optimization for R -PAC Production

Process Optimization for R -PAC Production. N. Leksawasdi 1 , M. Breuer 2 , B. Hauer 2 , P.L. Rogers 1 , B. Rosche 1. 1 BABS, UNSW, Sydney, NSW, 2052, Australia. 2 BASF-AG, 67056 Ludwigshafen, Germany. What is R-PAC. R-PAC is for R - P henyl- A cetyl- C arbinol.

ariane
Télécharger la présentation

Process Optimization for R -PAC Production

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Process Optimization for R-PAC Production N. Leksawasdi1, M. Breuer2, B. Hauer2, P.L. Rogers1, B. Rosche1 1BABS, UNSW, Sydney, NSW, 2052, Australia 2BASF-AG, 67056 Ludwigshafen, Germany

  2. What is R-PAC • R-PAC is for R-Phenyl-Acetyl-Carbinol • Precursor for production of ephedrine & pseudoephedrine; used to treat asthma and flu symptoms

  3. PDC catalysed reactions PDC

  4. Process of model development • Theoretical for general model structure • Experimental for model structure modification & evaluation of constants • Combined theoretical & experimental • Confirmation of model by independent batch biotranformation profile • Optimization by designing feeding profile for fed batch system

  5. Theoretical model development According to King and Altman (1956) Full form Simplified form

  6. Theoretical model Product Reactants By-products

  7. Experimental model development Quantification of kinetics • Enzyme activity • Substrate concentrations • Enzyme deactivation effect • Batch biotransformations for Overall rate of R-PAC formation Rate constants of by-products formation

  8. Enzyme activity effect

  9. Kb = 1 x 10-4 mM-1.34 h = 2.34 [Benzaldehyde] effect Monod-Wyman-Changeux (MWC) Model R2 = 0.9963

  10. [Pyruvate] effect Michaelis – Menten kinetics Model R2 = 0.9973 Km = 10.6 mM

  11. Enzyme deactivation effect 0 mM 60 mM Bz

  12. 120 100 0 mM 80 Relative enzyme activity (%) 60 40 20 200 mM 0 0 20 40 60 80 100 120 140 Time (h) Enzyme deactivation by benzaldehyde R2 = 0.9827

  13. Enzyme deactivation effect Kd1 = 2.64 x 10-3 h-1 kd2 = 1.98 x 10-4 mM -1 h-1 tlag = 5.23 h

  14. Overall rate constant & by-product rate constants determination Independent prediction and confirmation k2, Vq, Vr

  15. Batch biotransformation R2 = 0.9857

  16. Batch biotransformation R2 = 0.9981

  17. Overall & by-products rate constants Overall rate constant (k2 ) = 24.8 mmol h-1 U-1 Acetaldehyde rate constant (Vq ) = 0.0156 h-1 (U/ml) -1 Acetoin rate constant (Vr ) = 0.00251 h-1 (U/ml) -1 mM-1

  18. Theoretical & experimental model

  19. Simulation of biotransformation

  20. Confirmation of simulation R2 = 0.9953

  21. Model application in fed-batch system • Suggestion of substrates level to be maintained for optimum R-PAC production • Pulse feeding can be designed to achieve optimum R-PAC production • Prediction of fed-batch biotransformation profile

  22. Simulation for prediction of optimum substrate level Hourly feed 1.2 Pyr/Bz Initial Volume 1.00 L 4.0 U/ml PDC

  23. Feeding profile for 90 mM Bz, 108 mM Pyr Hourly feed 10.3 M Bz Hourly feed 1.4 M Pyr Initial Volume 1.00 L

  24. Predictive fed-batch profile 89 mg/U Initial Volume 1.00 L Final Volume 3.39 L

  25. Conclusions • Model provides good prediction for batch biotransformation system • Model suggests substrate levels in the range of 90 mM Bz & 108 mM Pyr to be maintained in fed-batch system • Potential for 8-fold higher R-PAC per U than in batch system but verification by experiment is necessary Note : Possible additional effects of inhibition (high R-PAC, acetaldehyde conc.) and inactivation (benzaldehyde droplets) may need to be considered

  26. Royal Thai Government, BASF-AG • Professor Peter L. Rogers, Dr. Bettina Rosche • Dr. Vanessa Sandford • Dr. Russell Cail & Malcolm Noble • Dr. Christopher Marquis • Wolfgang Nittel, Sue Jackson • Martin Zarka & Tony Gellert • Mallika Boonmee, Alan Rushby • Lia, Allen, Cindy, Onn, Ronachai, Apple Acknowledgements

  27. Questions

More Related